Mix-up Of Two Anti-Hypertension Drugs Sold In U.S. Prompts India's Lupin To Recall Product

MUMBAI - One of India's leading pharmaceutical companies Lupin Laboratories Ltd. has initiated a recall of its key ACE inhibitor lisinopril. Lupin had U.S. sales of roughly $45 million from the single drug, said a source closely tracking the news